Air-Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations
- PMID: 32953944
- PMCID: PMC7500038
- DOI: 10.1089/aivt.2017.0034
Air-Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations
Abstract
In vitro air-liquid interface (ALI) cell culture models can potentially be used to assess inhalation toxicology endpoints and are usually considered, in terms of relevancy, between classic (i.e., submerged) in vitro models and animal-based models. In some situations that need to be clearly defined, ALI methods may represent a complement or an alternative option to in vivo experimentations or classic in vitro methods. However, it is clear that many different approaches exist and that only very limited validation studies have been carried out to date. This means comparison of data from different methods is difficult and available methods are currently not suitable for use in regulatory assessments. This is despite inhalation toxicology being a priority area for many governmental organizations. In this setting, a 1-day workshop on ALI in vitro models for respiratory toxicology research was organized in Paris in March 2016 to assess the situation and to discuss what might be possible in terms of validation studies. The workshop was attended by major parties in Europe and brought together more than 60 representatives from various academic, commercial, and regulatory organizations. Following plenary, oral, and poster presentations, an expert panel was convened to lead a discussion on possible approaches to validation studies for ALI inhalation models. A series of recommendations were made and the outcomes of the workshop are reported.
Keywords: air–liquid interface; in vitro; inhalation; lung cell models; toxicology; validation.
© Ghislaine Lacroix et al., 2018; Published by Mary Ann Liebert, Inc.
Conflict of interest statement
The authors reported no competing financial interests.
Figures
References
-
- Paur HR, Mülhopt S, Weiss C, et al. . In vitro exposure systems and bioassays for the assessment of toxicity of nanoparticles to the human lung. J Verbrauch Lebensm 2008:3;319–329
-
- Paur H-R, Cassee FR, Teeguarden J, et al. . In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung—A dialog between aerosol science and biology. J Aerosol Sci 2011:42;668–692
-
- Landsiedel R, Sauer UG, Ma-Hock L, et al. . Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine (Lond) 2014:9;2557–2585 - PubMed
-
- WHO. Ambient air pollution: a global assessments of exposure and burden of disease. http://apps.who.int/iris/bitstream/10665/250141/1/9789241511353-eng.pdf (last accessed March5, 2018)
-
- Schmid O, Jud C, Umehara Y, et al. . Biokinetics of aerosolized liposomal ciclosporin A in human lung cells in vitro using an air-liquid cell interface exposure system. J Aerosol Med Pulm Drug Deliv 2017:30;411–424 - PubMed
Publication types
LinkOut - more resources
Full Text Sources